Search results
When to get your moles checked, after Kevin Jonas recovers from surgery
Press Association News via AOL· 53 minutes ago“Basal cell carcinoma is either a flat red patch of skin that bleeds or is painful but also a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 20 hours agoThe companies are also testing the combo in patients with melanoma, non-small cell lung cancer,...
Cantor Fitzgerald L. P. Has $362,000 Stock Holdings in Adlai Nortye Ltd. (NASDAQ:ANL)
ETF DAILY NEWS· 9 hours agoCantor Fitzgerald L. P. boosted its position in Adlai Nortye Ltd. (NASDAQ:ANL – Free Report) by 128.2% during the fourth quarter, according to the company in its most recent 13F filing with ...
MyMichigan Health: ABCDE of Melanoma
Midland Daily News· 4 days agoSkin cancer is the most common type of cancer in the United States, and it's estimated that one in five Americans will develop skin cancer in their...
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 1 day agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
Former Aggie RB Darren Lewis turns life around and is now fighting for it
The Bryan-College Station Eagle· 15 hours agoThe 5-foot-10, 219-pound Lewis was virtually unstoppable from the first time he walked onto a...
Congenital Pigment Disorders May Need Special Management
Medscape· 9 hours agoCongenital disorders of pigmentation are numerous and can have mild to severe effects, and some have...
Merus N.V. VP controller Harry Shuman sells shares worth over $475,000 By Investing.com
Investing.com· 17 hours agoIn a recent transaction, Harry Shuman, the VP Controller and Principal Accounting Officer (PAO) of...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 6 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 6 days agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...